Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)

Morocco flag Morocco · Delayed Price · Currency is MAD
950.00
-38.00 (-3.85%)
At close: Apr 24, 2025
0.96%
Market Cap 950.00M
Revenue (ttm) 805.52M
Net Income (ttm) 56.90M
Shares Out 1.00M
EPS (ttm) 56.90
PE Ratio 16.70
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Average Volume 22
Open 950.00
Previous Close 988.00
Day's Range 950.00 - 950.00
52-Week Range 873.00 - 1,150.00
Beta -0.15
RSI 47.96
Earnings Date Apr 25, 2025

About CBSE:PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. operates as a subsidiary of Hikma Pharmaceuticals PLC. [Read more]

Industry Pharmaceutical Preparations
Founded 1947
Employees 343
Stock Exchange Casablanca Stock Exchange
Ticker Symbol PRO
Full Company Profile

Financial Performance

In 2023, CBSE:PRO's revenue was 805.52 million, an increase of 14.32% compared to the previous year's 704.64 million. Earnings were 56.90 million, a decrease of -24.42%.

Financial Statements

News

There is no news available yet.